公司资料
InMed 股价、新闻与催化剂
- 股票代码:
- INM
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- Canada and listed in the U
股票表现
1.46 USD (-0.68%)
收盘价
最后更新: 2026年8月17日
5.04M USD
市值
股价为何变动
As of Aug 17, 2026, INM closed down 0.68% at $1.46. No new same-company headline was identified in the current news window.
公司概览
业务概览
InMed Pharmaceuticals is a biotechnology company focused on cannabinoids and related pharmaceutical applications. Its story is centered on whether cannabinoid science can be translated into differentiated medicines.
所在地与行业分类
InMed is headquartered in Canada and listed in the U.S. market. It sits in small-cap biotechnology with a cannabinoid focus.
商业模式特征
The company depends on clinical and preclinical validation, regulatory clarity, and capital efficiency. Investors usually watch early data, platform direction, and whether the company can sharpen its therapeutic thesis.
生物医药行业定位
InMed occupies a niche cannabinoid biotech position. The stock is catalyst-sensitive because the company must prove both scientific and commercial relevance.
未来催化剂
- InMed’s catalysts are pharmaceutical-cannabinoid programs and any update that clarifies whether the company can still turn the platform into a viable development path. The market will care about human proof.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。